← Eichor
Condition: Monoclonal Gammopathy Of Undetermined Significance Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Monoclonal Gammopathy Of Undetermined Significance

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
Phase N/A · 4 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT07214324Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS
Phase N/A · 2 location(s) · University Hospital, Rouen · NCT06559033AutoInflammatory Disease Alliance Registry (AIDA)
Phase N/A · 112 location(s) · University of Siena · NCT05200715A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined S
NA · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT05640843Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Phase N/A · 7 location(s) · Dana-Farber Cancer Institute · NCT02269592Intestinal Flora and Immunity in Monoclonal Gammopathy Patients
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT06539832Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
Phase N/A · 1 location(s) · University of Miami · NCT05361694A Prospective Long-term Observational Study in Patients With Monoclonal Gammopathy of Undetermined Significance
Phase N/A · 1 location(s) · Oxford University Hospitals NHS Trust · NCT05539079Sleep Apnea in Patients With MGUS and MM
Phase N/A · 1 location(s) · Michael Tomasson · NCT04114084The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland
Phase 2 · 1 location(s) · Helsinki University Central Hospital · NCT06889948CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT06644625The Indiana Myeloma Registry
Phase N/A · 1 location(s) · Indiana University · NCT03616483Whole Body MRI in Oncology
Phase N/A · 3 location(s) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRS · NCT06895291Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT02726750Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT06690593A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
Phase N/A · 1 location(s) · Peking University First Hospital · NCT05283993A Study to Assess the Effectiveness and Safety of Canakinumab in Clinical Use in Patients With Schnitzler's Syndrome
Phase N/A · 2 location(s) · Novartis Pharmaceuticals · NCT07598422A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of
Phase 2 · 11 location(s) · Memorial Sloan Kettering Cancer Center · NCT06083922Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD
Phase 2 · 3 location(s) · Peking University People's Hospital · NCT06418477The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study
Phase N/A · 1 location(s) · Shanghai Zhongshan Hospital · NCT05965115Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT05136807A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gam
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06055894National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Phase N/A · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT01408225Pre-malignant States to Hematologic Malignancies in Firefighters
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT06870760Registry for Adults With Plasma Cell Disorders (PCD's)
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT03717844Promoting Diagnosis and Management of AL in Italy (ProDigALIty)
Phase N/A · 4 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06383143Rifaximin Versus No Intervention for the Treatment of IgA Monoclonal Gammopathy of Undetermined Significance
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT07209371A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple My
Phase 2 · 39 location(s) · Regeneron Pharmaceuticals · NCT06140524FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Pre
NA · 1 location(s) · University of Miami · NCT07446777
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.